These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8361860

  • 1. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 4. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 5. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 6. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 7. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Jul; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 8. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 9. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Apr 21; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 10. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK.
    Am J Manag Care; 2002 Sep 21; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [Abstract] [Full Text] [Related]

  • 11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 21; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 12. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Dec 21; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 13. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D, Krone W.
    Herz; 1995 Feb 21; 20(1):33-46. PubMed ID: 7713475
    [Abstract] [Full Text] [Related]

  • 14. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Feb 21; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 15. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.
    Am J Cardiol; 2008 Feb 15; 101(4):486-9. PubMed ID: 18312763
    [Abstract] [Full Text] [Related]

  • 16. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A.
    Exp Clin Endocrinol Diabetes; 2003 Aug 15; 111(5):239-45. PubMed ID: 12951627
    [Abstract] [Full Text] [Related]

  • 17. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J, James RW, Makoundou V, Bioletto S, Golay A.
    Diabetes Metab; 2001 Dec 15; 27(6):701-8. PubMed ID: 11852380
    [Abstract] [Full Text] [Related]

  • 18. Dyslipoproteinaemia in manifest diabetes.
    Manzato E, Crepaldi G.
    J Intern Med Suppl; 1994 Dec 15; 736():27-31. PubMed ID: 7986305
    [Abstract] [Full Text] [Related]

  • 19. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 15; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 20. Diabetic dyslipidaemia.
    Erkelens DW.
    Eur Heart J; 1998 Jul 15; 19 Suppl H():H27-40. PubMed ID: 9717062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.